Let's Talk

MALDI-ToF White Paper published by European Pharmaceutical Review

Date of event 13th January 2016

We are delighted to announce the publication of our recent MALDI-ToF white paper (Mass Spectrometry), by the European Pharmaceutical Review:

MALDI-ToF Mass Spectrometry – A valid alternative for microbial identification

Rapid and accurate identification of pathogenic microorganisms in areas such as pharmaceutical and medical device manufacturing are of paramount importance. Traditional identification techniques often require subcultures on selective medium, colony isolation, Gram staining or biochemical testing, which are labour intensive and time consuming.

Rapid microbiological methods (RMMs) for microbial identification have been widely adopted by the clinical microbiology environment due to their speed and accuracy resulting in reduced risk and improved patient safety. Furthermore, as RMMs generally reduce product release cycle time, labour and cost alongside supporting real-time data analysis and high throughput, it is unsurprising that these technologies are also being adopted by the pharmaceutical and medical device industries.

Matrix Assisted Light Desorption Ionisation Time-of Flight (MALDI-ToF)